Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia

Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients around the world by leveraging Bristol Myers Squibb’s long-standing expertise in immune-mediated diseases Zenas will receive a $50 million

Read More

GASOLINE, DIESEL PRICES DROP

The price of a 95-octane gasoline dropped on Tuesday by LBP 7,000, that of 98-octane gasoline by LBP 8,000, and that of diesel by LBP 7,000, while the price of

Read More